Capital Wealth Alliance’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$223K Hold
242
0.1% 86
2025
Q4
$253K Buy
+242
New +$231K 0.11% 76
2024
Q2
Sell
-260
Closed -$203K 111
2024
Q1
$203K Buy
+260
New +$185K 0.12% 98
2020
Q1
Sell
-245
Closed -$34K 220
2019
Q4
$34K Buy
+245
New +$28.4K 0.03% 161

Other funds holding LLY

Capital Wealth Alliance's LLY Position: Q1 2026 in Review

Capital Wealth Alliance held its Eli Lilly (LLY) position steady in Q1 2026 at 242 shares worth $223K. The position accounts for 0.1% of the portfolio, ranked #86.

Capital Wealth Alliance first reported a position in LLY in Q4 2019 and has held it in 4 quarters since. The position peaked at $253K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital Wealth Alliance held 242 shares of Eli Lilly worth $223K as of Q1 2026.
  • Capital Wealth Alliance left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.1% of Capital Wealth Alliance's portfolio in Q1 2026, its #86 holding.
  • Capital Wealth Alliance first reported a position in Eli Lilly in Q4 2019 and has held it in 4 quarters since.
  • Capital Wealth Alliance's Eli Lilly position peaked at $253K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.